CClinicalTrials.gg
Not yet recruitingNCT06264869Updated Feb 20, 2024

Interdental Guided Creeping Technique

An interventional study of Interdental guided creeping technique (IGCT) and connective tissue graft (CTG) and Interdental guided creeping technique (IGCT) and collagen membrane (CM) in Interdental Papilla Recession, sponsored by October 6 University. Not yet recruiting. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by October 6 University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The aim of this randomized clinical trial is to treat interdental papillary deficiency with minimally invasive interdental guided creeping technique (IGCT) comparing collagen membrane versus connective tissue graft.

02

Conditions studied

  • Interdental Papilla Recession

Keywords

  • Interdental papilla loss
  • Interdental papilla deficiency
  • Interdental papilla recession
  • Black triangle
  • Connective tissue graft
  • Collagen membrane
  • Minimally Invasive Surgery
  • Tunneling Techniques
  • Creeping Attachment
  • Plastic periodontal surgery
03

In context

Lead sponsor

October 6 University is the lead sponsor of 135 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy patients having interdental papilla deficiency.
  • Good Oral Hygiene.
  • Age range: 18 - 50 years.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactation.
  • Smokers.
  • Alcoholic patients and drug abusers.
  • Handicapped and prisoners.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    IGCT + CTG

    Interdental guided creeping technique (IGCT) + Connective tissue graft (CTG)

    Procedure: Interdental guided creeping technique (IGCT) and connective tissue graft (CTG)

  • Experimental
    IGCT + CM

    Interdental guided creeping technique (IGCT) + Collagen membrane (CM)

    Procedure: Interdental guided creeping technique (IGCT) and collagen membrane (CM)

Interventions

  • ProcedureInterdental guided creeping technique (IGCT) and connective tissue graft (CTG)

    Interdental guided creeping technique (IGCT) and connective tissue graft (CTG)

  • ProcedureInterdental guided creeping technique (IGCT) and collagen membrane (CM)

    Interdental guided creeping technique (IGCT) and collagen membrane (CM)

06

What researchers measure

Primary outcomes

  1. Black triangle height

    In mm

    Time frame: Baseline, 1, 3 and 6 months.

Secondary outcomes

  1. Percentage of interdental papillary fill

    In %

    Time frame: Baseline, 1, 3 and 6 months.

  2. Papillary gain, black triangle reduction

    In mm, %

    Time frame: Baseline, 1, 3 and 6 months.

  3. Papillary height, attached gingiva width

    In mm

    Time frame: Baseline, 1, 3 and 6 months.

  4. Pocket depth, clinical attachment level, keratinized tissue thickness

    In mm

    Time frame: Baseline, 3 and 6 months.

  5. Plaque index

    Scores

    Time frame: Baseline, 1, 3 and 6 months.

  6. Gingival index

    Scores

    Time frame: Baseline, 1, 3 and 6 months.

  7. Duration of surgery

    In minutes

    Time frame: At time of surgery

  8. Patient Reported Outcome

    VAS score for pain

    Time frame: At the day of surgery and the 1st 10 days postoperative.

  9. Patient Reported Outcome

    Patient satisfaction (score)

    Time frame: 1, 3 and 6 months.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06264869
Lead sponsor
October 6 University
Responsible party
Ahmed Y Gamal (Professor of Oral Medicine, Periodontology and Oral Diagnosis, Faculty of Dentistry, Ain Shams University. Professor of Periodontology, College of Oral and Dental Surgery, Misr University for Science and Technology., Ain Shams University) — Principal investigator
First posted
Feb 20, 2024
Start date
Feb 2024 (estimated)
Primary completion
Nov 2024 (estimated)
Completion
Nov 2024 (estimated)
Last update
Feb 20, 2024

Study contacts

Gamal
Contact
hgamal1@hotmail.com
01006607176
A.GamalElDin
Contact
g.ag.ghada@gmail.com
Ghada G A.GamalElDin, Dr.
principal investigator · PhD Student of Periodontology, Faculty of Dentistry, Cairo University
Mohamed S. Morgan, Dr.
principal investigator · Master Student of Periodontology, Faculty of Dentistry, Ain Shams University
Ahmed Y Gamal, Prof.
study director · Professor of Oral Medicine, Periodontology and Oral Diagnosis - Faculty of Dentistry - Ain Shams University, Professor of Periodontology - College of Oral and Dental Surgery - Misr University for Science and Technology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion